Your SlideShare is downloading. ×
  • Like
quest diagnostics 9_10BearStearns9_11_07
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

quest diagnostics 9_10BearStearns9_11_07



  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Bear Stearns Healthcare Conference September 11, 2007
  • 2. Safe Harbor Disclaimer » » The statements in this presentation which are not historical facts or information are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are described in the Quest Diagnostics Incorporated SEC filings, including our latest Form 10-K. Additional risks may arise from unanticipated events. A copy of this presentation is available on our website at Patients Growth People
  • 3. Who is Quest Diagnostics? » »Leader in Providing Healthcare Insights and Solutions Comprehensive Diagnostic Testing Routine ——» Esoteric • Diagnose • Monitor • Predict • Prevent Advanced Information Technology Solutions Improve Care and Efficiency Facilitate Introduction of New Therapeutics Clinical Trials Testing Touching the Lives of Patients >150 Million Times in 2006 Patients Growth People
  • 4. Quest Diagnostics: The Leader » » DiagnosticBTesting US Market: ~$45 Source: Washington G-2 Reports and company estimates Quest Diagnostics data is proforma for AmeriPath acquisition Patients Growth People
  • 5. A Leader Across All Product Lines » » $ in millions Based on 2006 Actual Results, proforma for AmeriPath acquisition Patients Growth People
  • 6. Favorable Industry Trends » » Essential Healthcare Service Growing and Aging Population Innovations in Science & Medicine Personal Interest in Health Convergence of Technologies • Genetic Predisposition • Diagnostic Testing • Diagnostic Imaging • Information Technology Influences >70% of Healthcare Decisions Patients Growth People
  • 7. Why Quest Diagnostics? » » Unique Value Proposition Superior Patient Experience Six Sigma Quality Unparalleled Access and Distribution Innovative Science & Medicine Advanced Information Technology Sustainable Advantage Patients Growth People
  • 8. Expanding Usage by Patients of PSC Appointment Scheduling » » Patients Growth People
  • 9. Unparalleled Access and Distribution » » Serving 50% of US Hospitals & Physicians 31 Regional Laboratories 2 Comprehensive Esoteric Laboratories 150 Rapid Response Laboratories 40 Outpatient AP Facilities in 19 States ~2,100 Patient Service Centers - serving 45 million patients each year 4,000 Vans and 20 Airplanes - making 95,000 stops each day 45,000 Dedicated Employees Touching the Lives of Patients >150 Million Times in 2006 Patients Growth People
  • 10. Patient Service Centers and Laboratory Network » » PSCs IOPs RRLs ∃ Main Labs ∃ ~2,300 Laboratories and Patient Service Centers Serving Half of US Physicians Patients Growth People
  • 11. Electronic Connectivity: Care360 Network » » >115,000 Physician Users and Growing by >1,000 Physicians Each Month Patients Growth People
  • 12. Approach to Driving Profitable Growth » » Building a Sustainable Competitive Advantage Provide Differentiated Service at Competitive Prices Focus on High Growth Segments Cancer Diagnostics Cardiovascular Disease Infectious Disease Molecular Diagnostics Introduce Important & Unique Tests & Services Expand Geographic Scope Expand Diagnostic Scope – Near Patient Testing Increasing Loyalty with Patients, Physicians and Payers Patients Growth People
  • 13. AmeriPath Acquisition » » Creates Leader in Cancer Diagnostics National Scale with Significant Local Presence • 900 MDs and PhDs • Over 200 Hospital Contracts in 22 States • Approximately 40 Outpatient Anatomic Pathology Facilities in 19 States Strengthens Leadership in Hospital and Esoteric Testing Strengthens Relationship with Physicians and Payers Accelerates Revenue and Earnings Growth Integration Activities are On Track Patients Growth People
  • 14. Near Patient Testing » » An Opportunity to Improve Patient Care and … Attractive benefits for hospitals and physician offices Enables more timely and effective decisions Expanding product menu Combine with central lab results to create complete patient testing record available to physicians and plans …to Reduce Medical Costs Patients Growth People
  • 15. Improving Revenue Mix to Higher Margin, Differentiated Services » » Quest Diagnostics 2002 Revenue Quest Diagnostics 2006 Pro Forma Revenue Other Other 3% 7% Drugs of Abuse Gene-based and Esoteric Drugs of Abuse Gene-based and Esoteric 4% 16% 3% 17% Anatomic Pathology Anatomic Pathology 10% 17% Routine Routine 67% 56% Total Revenue: $4.1 Billion Total Pro Forma Revenue: ~$7.0 Billion Patients Growth People
  • 16. 2007 Guidance * » » A Challenging Environment in 2007 Revenues $6.6 billion to $6.7 billion Operating Income ~16% EPS $2.80 – $2.95 Cash from Operations ~$800 million CapEx $210 - $220 million Returning to Revenue and Earnings Growth in 2008 *Excludes $0.04 EPS in Q1 charges. Patients Growth People
  • 17. Building on Strength » » Industry Leader in a Vital and Growing Industry −Leadership in All Major Segments Unique Value Proposition A Proven Track Record of Integrating Acquisitions Proven Management Team Strong Cash Generator A History of Disciplined Growth Patients Growth People
  • 18. » » Patients Growth People